Latest filing published 19 Aug 2009 for CADENCE PHARMACEUTICALS INC, €7,144.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael A. Berman: trading record in brief
This profile gathers the share dealings of Michael A. Berman in Cadence Pharmaceuticals Inc. Over a trading history stretching from 1 November 2006 to 18 August 2009, the count stands at 37 filings.
The open-market record is one-sided, with 26 purchases worth €235k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 11 share grants.
In size, the median ticket on the buying side is €3,359.
Most recently, on 19 August 2009, the filings show a share grant worth €7,144 in Cadence Pharmaceuticals Inc. The most recent open-market purchase was published on 19 May 2008, 6,748 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael A. Berman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$10.12Common StockSEC:0001209191-09-041317:0
- 1,000 shares@ US$9.94Common StockSEC:0001209191-09-041317:1
- 400 shares@ US$10.75Common StockSEC:0001209191-09-040893:0
- 2,500 shares@ US$10.58Common StockSEC:0001209191-09-040893:1
- 1,300 shares@ US$10.90Common StockSEC:0001209191-09-040315:0
- 900 shares@ US$10.90Common StockSEC:0001209191-09-040315:1
- 300 shares@ US$10.90Common StockSEC:0001209191-09-040315:2
- 265 shares@ US$9.57Common StockSEC:0001209191-09-028213:0
- 120 shares@ US$9.59Common StockSEC:0001209191-09-028213:1
- 190 shares@ US$9.58Common StockSEC:0001209191-09-028213:2
- 8,200 shares@ US$9.58Common StockSEC:0001209191-09-027923:0
- 1,000 shares@ US$6.10Common StockSEC:0001209191-08-031362:0Canonical exit: 13 Aug 2008 (T+90)
- 3,800 shares@ US$6.33Common StockSEC:0001209191-08-031362:1Canonical exit: 14 Aug 2008 (T+90)
- 800 shares@ US$6.24Common StockSEC:0001209191-08-031362:2Canonical exit: 14 Aug 2008 (T+90)
- 100 shares@ US$6.22Common StockSEC:0001209191-08-031362:3Canonical exit: 13 Aug 2008 (T+90)
- 2,900 shares@ US$6.33Common StockSEC:0001209191-08-031362:4Canonical exit: 14 Aug 2008 (T+90)
- 900 shares@ US$6.33Common StockSEC:0001209191-08-031362:5Canonical exit: 14 Aug 2008 (T+90)
- 600 shares@ US$6.33Common StockSEC:0001209191-08-031362:6Canonical exit: 14 Aug 2008 (T+90)
- 300 shares@ US$9.54Common StockSEC:0001209191-08-020323:3Canonical exit: 30 Jan 2007 (T+90)
- 270 shares@ US$5.76Common StockSEC:0001209191-08-019356:0Canonical exit: 15 Jun 2008 (T+90)
- 1,000 shares@ US$5.30Common StockSEC:0001209191-08-019356:1Canonical exit: 15 Jun 2008 (T+90)
- 140 shares@ US$5.15Common StockSEC:0001209191-08-019356:2Canonical exit: 15 Jun 2008 (T+90)
- 1,000 shares@ US$5.28Common StockSEC:0001209191-08-019356:3Canonical exit: 15 Jun 2008 (T+90)
- 400 shares@ US$5.37Common StockSEC:0001209191-08-019356:4Canonical exit: 15 Jun 2008 (T+90)
- 100 shares@ US$5.36Common StockSEC:0001209191-08-019356:5Canonical exit: 15 Jun 2008 (T+90)
25 of 33 declarations